However, a comprehensive study of epigenetic landscapes in acute lymphoblastic leukemia (ALL) found no role for KMT2D mutations in GC resistance-associated chromatin accessibility changes (66). This evidence concerns the gene KMT2D and acute lymphoblastic leukemia.